Akari Therapeutics Plc 10-Q filing
Filed 2025-11-13 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001493152-25-022390
- Form type
- 10-Q
- CIK
- 0001541157
- Primary document
- https://www.sec.gov/Archives/edgar/data/1541157/000149315225022390/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Akari Therapeutics Plc.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-14.0M | - | - |
| Net Income | $-12.0M | - | - |
| Eps Basic | 0 | - | - |
| Eps Diluted | 0 | - | - |
| Total Assets | $45.4M | - | - |
| Total Liabilities | $22.7M | - | - |
| Shareholders Equity | $22.7M | - | - |
| Operating Cash Flow | $-7.5M | - | - |